Literature DB >> 14894574

The use of ACTH and cortisone in ophthalmology.

D M GORDON, J M McLEAN, H KOTEEN, F P BOUSQUET, W D McCUSKER, I BARAS, P WETZIG, E W D NORTON.   

Abstract

Entities:  

Keywords:  ACTH/therapeutic use; CORTISONE/therapeutic use; EYE/diseases

Mesh：

Substances：

Year:  1951        PMID： 14894574     DOI： 10.1016/0002-9394(51)90032-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  15 in total

1.  [The eye in premature infants with special reference to retrolental fibroplasia].

Authors:  J A CASTREN
Journal:  Klin Wochenschr       Date:  1959-02-15

2.  Central serous retinopathy.

Authors:  G BENNETT
Journal:  Br J Ophthalmol       Date:  1955-10       Impact factor: 4.638

3.  Present status of corticotropin; ACTH, cortisone, and hydrocortisone in ophthalmology.

Authors:  D M GORDON; J M MCLEAN; H KOTEEN
Journal:  Br J Ophthalmol       Date:  1953-02       Impact factor: 4.638

4.  Macular degeneration treated with cortisone.

Authors:  H E HOBBS
Journal:  Proc R Soc Med       Date:  1953-03

5.  Possible applications of adrenocorticotrophic hormone (ACTH) and cortisone in syphilis.

Authors:  G O HORNE
Journal:  Br J Vener Dis       Date:  1952-09

6.  Uses and limitations of ACTH and cortisone in ophthalmology.

Authors:  A C WOODS
Journal:  Br J Ophthalmol       Date:  1952-08       Impact factor: 4.638

7.  Reduction of steroid-induced intraocular pressure elevation in sheep by tissue plasminogen activator.

Authors:  Rosana Gerometta; Sandeep Kumar; Shaily Shah; Larry Alvarez; Oscar Candia; John Danias
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-03       Impact factor: 4.799

8.  Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids.

Authors:  Thania Bogarin; Sindhu Saraswathy; Goichi Akiyama; Xiaobin Xie; Robert N Weinreb; Jie Zheng; Alex S Huang
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

9.  Cyclophosphamide for ocular inflammatory diseases.

Authors:  Siddharth S Pujari; John H Kempen; Craig W Newcomb; Sapna Gangaputra; Ebenezer Daniel; Eric B Suhler; Jennifer E Thorne; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; C Stephen Foster
Journal:  Ophthalmology       Date:  2009-12-06       Impact factor: 12.079

10.  Methods to Induce Chronic Ocular Hypertension: Reliable Rodent Models as a Platform for Cell Transplantation and Other Therapies.

Authors:  Ashim Dey; Abby L Manthey; Kin Chiu; Chi-Wai Do
Journal:  Cell Transplant       Date:  2018-02       Impact factor: 4.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.